• BX Home
  • Merck & Co.: News [Page 10]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MERCK & CO.

Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.

Merck & Co. is part of Business Exchange, suggested by Ginny Moore. This topic contains 967 news and 178 blog items. Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from like-minded professionals.

News

Recent news on this topic.

Stocks: Focus on earnings, gold and dollarmore

earnings reports," said Wyss. Ahead of Friday's opening bell, Dow components Caterpillar (CAT, Fortune 500) and...

Dollar Weakens on Economy; U.S. Stock Futures Gain on Earningsmore

first-quarter profit of $1.84 a share, more than the $1.31 average estimate in a Bloomberg survey. Merck & Co.

Merck's Profit Rises as Drug Sales Increasemore

first-quarter profit jumped as the drug maker registered increased sales and accounting adjustments took less of a toll.

U.S. Futures Narrowly Mixedmore

May 20, 2008, driven by upbeat corporate results. Ahead of the market open on Friday, Caterpillar, Chevron and Merck...

Merck Profit Tops Analyst Estimates on Higher Drug Salesmore

April 29 (Bloomberg) -- Merck & Co., the second-largest U.S. drugmaker, reported first-quarter profit that topped...

Merck reports higher-than-expected earningsmore

Merck & Co (MRK.N) reported higher-than-expected first-quarter earnings, fueled by strong sales of its drugs for...

5 Stocks to Watch: Merck, RIMmore

NEW YORK (TheStreet) -- Drug giant Merck(MRK) was rising 1.9% to $36.45 in premarket trading Friday after reporting...

Merck triples its first-quarter profitmore

NEW YORK (MarketWatch) -- Merck & Co. (NYSE:MRK

Merck Q1 net triples on lower charges, flat salesmore

WHITEHOUSE STATION, N.J. ? Merck & Co. says its first-quarter profit more than tripled despite only slightly higher...

Stocks to watch Friday: NYSE Euronext, RIM, Merckmore

shares are expected to see active trade in Friday��s session are blue chips Caterpillar Inc., Chevron Corp.

Morning MarketBeat: Caterpillar, Chevron Lead Earnings Parademore

reports, along with Microsofts late Thursday results, will probably drive the market direction. Among them:...

Stocks to Watch: Stocks to watch Friday: NYSE Euronext, RIM, Merckmore

are expected to see active trade in Friday���s session are blue chips Caterpillar Inc., Chevron Corp. and Merck &...

Dollar, Oil Decline on Economy Concern as Greek Bonds Retreatmore

Inc.���s business barometer and the Thomson Reuters/University of Michigan April final index of consumer sentiment for...

Stock end April sharply highermore

mixed earnings reports and disappointing GDP and jobless claims reports.Companies: Dow components Chevron (CVX, Fortune...

Wall St ends week of bumper earningsmore

Extract not available.

Stocks finish month sharply highermore

mixed earnings reports and disappointing GDP and jobless claims reports.Companies: Dow components Chevron (CVX, Fortune...

Selected first-quarter drug sales for Merck & Co.more

Here are sales figures for the first quarter for Merck & Co.'s 10 top-selling drugs:PRODUCT NAME CONDITION/USE 1Q...

Stocks edge higher on earningsmore

mixed earnings reports and disappointing GDP and jobless claims reports.Companies: Dow components Chevron (CVX, Fortune...

Hepatitis C drug pitched to FDA panelmore

C virus offers an advance over the current decade-old treatment that cures only a minority of patients, maker Merck...

When Arbs Attack: The Battle Over Celeramore

that it opposed the transaction because it believes that ���the passive drug royalties which Celera owns, associated...

Merck Profit Soars on Lower Chargesmore

costs, while generic competition for previously big-selling drugs limited sales growth to 1%. The results exceeded...

The real winners in the pharma patent cliffmore

of all prescriptions, but four of the most commonly prescribed branded medications, Pfizer's Lipitor, AstraZeneca's...

At noon: RIM weighs on TSXmore

S. stocks held their ground in midday trading on Friday, following upbeat earnings reports from Caterpillar Inc.

WSJ's What's News Midday Edition, April 29, 2011more

Chevron earnings up 36% on higher oil prices, better margins; Caterpillar 1Q revenue up 57% on stronger sales; Merck...

Summary Box: Merck profit spikes in first quartermore

PROFIT SPIKE: Merck & Co.'s first-quarter profit more than tripled on lower costs from integrating Schering-Plough...

Top Sources: Merck & Co.

  • Reuters
  • BusinessWeek
  • Philadelphia Inquirer
  • MarketWatch
  • Financial Times
  • Wall Street Journal Online
  • businesswire.com
  • latimes.com
  • Economictimes
  • inpharm.com

Most Active Users in this Topic

see all contributors in Merck & Co.

Featured White Papers

Post a Job

Jobs in this Topic

Reliability Engineer Job Merck | Elkton, VA
Posted: May 23
Merck Account Executive TransPerfect Careers | New York, NY
Posted: Oct 22
Lead Business Analyst - Merck Research Labs IT Job Merck | Rahway, NJ
Posted: May 23

Report comment contains invalid characters. ()
cancel
Search Cancel